☰ Navigation Tabs
Crystal structure of the therapeutical antibody fragment of canakinumab in its unbound state External Resource: Annotation Chains Family Name Domain Identifier Architecture Possible Homology Homology Topology Family Provenance Source (Version) B [auth L] Prenyltransf e4g5zL1 A: alpha arrays X: GIY-YIG endonuclease H: GIY-YIG endonuclease T: GIY-YIG endonuclease F: Prenyltransf ECOD (v295.2) A [auth H] Prenyltransf e4g5zH1 A: alpha arrays X: GIY-YIG endonuclease H: GIY-YIG endonuclease T: GIY-YIG endonuclease F: Prenyltransf ECOD (v295.2)
Chain Protein Name Description Organism Name Gene Allele Name(s) Domain Name(s) Receptor Type Receptor Description Provenance Source B [auth L] INN name L-KAPPA Homo sapiens (human) IGKV6-21*01, IGKV6D-21*01, IGKV6D-21*02, IGKJ3*01, IGKC*01 V-DOMAIN V-KAPPA, C-DOMAIN C-KAPPA IG FAB-GAMMA-1_KAPPA IMGT (202636-0) A [auth H] INN name VH-CH1 Homo sapiens (human) IGHV3-33*01, IGHV3-33*04, IGHJ4*01, IGHJ4*02, IGHJ4*03, IGHG1*03 V-DOMAIN VH, C-DOMAIN CH1 IG FAB-GAMMA-1_KAPPA IMGT (202636-0)
Chain Chain Class Chain Subclass Chain Type Antigen Name(s) Provenance Source B [auth L] Light Chain IGKV1 Kappa - SAbDab (2026-09-18) A [auth H] Heavy Chain IGHV3 - - SAbDab (2026-09-18)